vimarsana.com

Page 6 - Proprietary Laboratory Analyses News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Menarini Silicon Biosystems s CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and.

United statesHuntingdon valleyFabio piazzalungaUs centers for medicareLaboratory analysesPrnewswire menarini silicon biosystems msb incMedicare clinical laboratory fee scheduleAmerican medical associationClinical laboratory improvement amendmentsMenarini groupMenarini silicon biosystems incMedicaid servicesMultiple myeloma cellTumor cellSilicon biosystemsCurrent procedural terminology

Menarini Silicon Biosystems s CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

- These new Codes are required to access Medicare/Medicaid insurance Reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 .

Laboratory analysesUs centers for medicareMenarinisiliconbiosystems msb incMenarini silicon biosystemsBiopsy testsReimbursement codesPreliminary pricing determinationMultiple myeloma cellTumor cellCurrent procedural terminologyProprietary laboratory analyses

Immunovia: CPT PLA Code for the IMMray™ PanCan-d test approved

/PRNewswire/ Immunovia AB (NASDAQ Stockholm: IMMNOV) announced, that Immunovia, Inc., its American subsidiary, has recently received approval for a Current.

United statesPhilipp mathieuLaboratory analysesCenters of medicare medicaid servicesEditorial panelAmerican medical associationImmunovia incCorporate communicationsClinical lab fee scheduleCurrent procedural terminologyProprietary laboratory analysesMedicaid servicesLab feeDirector investor relationsImmunovia ab

The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test

/PRNewswire/ Helio Genomics ("Helio"), and its commercial partner, Fulgent Genetics (NASDAQ: FLGT) ("Fulgent") announced that the American Medical.

United statesMelissa royNicole borsjeJustin chen liExchange commissionLaboratory analysesAmerican medical associationBlueshirt groupAmerican cancer societyFulgent geneticsCategoryi current procedural terminologyProprietary laboratory analysesChief executive officerHelio genomicsWest lafayettePrivate securities litigation reform act

Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association

/PRNewswire/ Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), has submitted an application for a Current Procedural.

United statesImmray pancan dPhilipp mathieuLaboratory analysesEditorial panelAmerican medical associationImmunovia incTechnical advisor group onCorporate communicationsNasdaq stockholmCurrent procedural terminologyProprietary laboratory analysesTechnical advisor groupDirector investor relationsImmunovia ab

vimarsana © 2020. All Rights Reserved.